Clinical trials
Phase 2 Parkinson Disease trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2018 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alkahest, Inc. | 1 |
| Antipodean Pharmaceuticals, Inc. | 1 |
| Impel Pharmaceuticals | 1 |
| Ken Marek, MD | 1 |
| Novartis | 1 |
| Novartis Pharmaceuticals | 1 |
| The University of Queensland | 1 |
| The University of Western Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 8 |
| Dyskinesias | 2 |
| Neurodegenerative Diseases | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Dyskinesia, Drug-Induced | 1 |
| Essential Tremor | 1 |
| Memory Disorders | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.